๐ฅ Moderna and Merck's Cancer Vaccine Cleared Phase 3. The Stock Doubled Before Anyone Saw the Numbers.
Moderna and Merck's personalized mRNA cancer vaccine cleared Phase 3 in 1,137 melanoma patients โ and Moderna's stock more than doubled before the full numbers were even released.